Literature DB >> 7532188

Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques.

K Fukuo1, T Inoue, S Morimoto, T Nakahashi, O Yasuda, S Kitano, R Sasada, T Ogihara.   

Abstract

To define the pathophysiological role of nitric oxide (NO) released from vascular smooth muscle cells (VSMC), we examined whether NO released from VSMC induces cytotoxicity in VSMC themselves and adjacent endothelial cells (EC) using a coculture system. Prolonged incubation with interleukin-1 (IL-1) induced large amounts of NO release and cytotoxicity in VSMC. NG-Monomethyl-L-arginine, an inhibitor of NO synthesis, inhibited both NO release and cytotoxicity induced by IL-1. In contrast, DNA synthesis in cocultured EC was not inhibited but rather stimulated by prolonged incubation with IL-1 or sodium nitroprusside (SNP), a NO donor. However, IL-1 and SNP did not stimulate but inhibited DNA synthesis in EC alone. On the other hand, conditioned medium from VSMC incubated for a long period with IL-1 or SNP stimulated DNA synthesis in EC alone. Furthermore, the concentration of basic fibroblast growth factor in the conditioned medium was increased and correlated with the degree of cytotoxicity in VSMC. These results indicate that NO released from VSMC induces VSMC death, which results in release of basic fibroblast growth factor, which then stimulates adjacent EC proliferation. Thus, NO released from VSMC may participate in the mechanism of neovascularization in atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532188      PMCID: PMC295533          DOI: 10.1172/JCI117712

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

Review 1.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

2.  Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor.

Authors:  A Baird; P Mormède; P Böhlen
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

3.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis.

Authors:  A C Barger; R Beeuwkes; L L Lainey; K J Silverman
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

4.  Corpus luteum angiogenic factor is related to fibroblast growth factor.

Authors:  D Gospodarowicz; J Cheng; G M Lui; A Baird; F Esch; P Bohlen
Journal:  Endocrinology       Date:  1985-12       Impact factor: 4.736

5.  Carotid artery stenosis following endarterectomy.

Authors:  R E Zierler; D F Bandyk; B L Thiele; D E Strandness
Journal:  Arch Surg       Date:  1982-11

6.  Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.

Authors:  C F Moyer; D Sajuthi; H Tulli; J K Williams
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

7.  Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.

Authors:  A Faggiotto; R Ross; L Harker
Journal:  Arteriosclerosis       Date:  1984 Jul-Aug

8.  The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques.

Authors:  A M Imparato; T S Riles; R Mintzer; F G Baumann
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

9.  Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery.

Authors:  R Ross; T N Wight; E Strandness; B Thiele
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

10.  Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor.

Authors:  J Nilsson; A G Olsson
Journal:  Atherosclerosis       Date:  1984-10       Impact factor: 5.162

View more
  15 in total

1.  Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1.

Authors:  Q Xu; Y Hu; R Kleindienst; G Wick
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system.

Authors:  David Pimentel; Dagmar Johanna Haeussler; Reiko Matsui; Joseph Robert Burgoyne; Richard Alan Cohen; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-03-15       Impact factor: 8.401

Review 3.  Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.

Authors:  Jing Zheng; Ian M Bird; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

Review 4.  Signaling regulation of fetoplacental angiogenesis.

Authors:  Kai Wang; Jing Zheng
Journal:  J Endocrinol       Date:  2011-11-21       Impact factor: 4.286

5.  Nitric oxide inhibits wounds collagen synthesis.

Authors:  A Shukla; A M Rasik; R Shankar
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

6.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.

Authors:  H M Kwon; G Sangiorgi; E L Ritman; C McKenna; D R Holmes; R S Schwartz; A Lerman
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide.

Authors:  D S Marks; J A Vita; J D Folts; J F Keaney; G N Welch; J Loscalzo
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

8.  Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane.

Authors:  E Pipili-Synetos; S Kritikou; E Papadimitriou; A Athanassiadou; C Flordellis; M E Maragoudakis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

9.  Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma).

Authors:  A Wangoo; I N Brown; B G Marshall; H T Cook; D B Young; R J Shaw
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 10.  Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

Authors:  George Kolios; Vassilis Valatas; Stephen G Ward
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.